Trump Releases Science Spending Priorities for FY2019

In a memo to federal agencies, the administration highlights defense and security, leaves off Earth and climate science, and limits the scope of basic research.

Written byAggie Mika
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, GAGE SKIDMOREThe Trump administration’s first official memo on science and technology spending, released yesterday (August 17), prioritizes national security and defense, economic prosperity, energy dominance, and public health. The document specifically calls out basic research as “critical,” but states that projects of “greater uncertainty” should give way to those that can be more readily developed into products and services.

According to a Science news report, the administration’s priorities are markedly different from those previously issued by the Obama administration and make no mention of “climate research, Earth observations, and advanced manufacturing.”

As far as basic science pursuits are concerned, the memo states that they “may not provide the economic incentive needed to attract private sector investment. Therefore, agencies should give priority to funding basic and early-stage applied research that, supplemented by private sector financing of later-stage R&D, can result in the development of transformative commercial products and services.”

With deadlines coming up next month for FY2019 budget requests, the annual memo, a collaboration between the White House Office of Science and Technology Policy (OSTP) and the Office of Management and Budget, is meant to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies